Godavari Biorefineries Limited has informed the Exchange about General Updates our Japanese patent application No. 2022-568620, titled Use of Compounds for Treating Viral Infections", has been granted by the Japan Patent Office
GODAVARIB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Biorefineries has been granted a patent by the Japan Patent Office (Patent No. 7824889) for its application titled 'Use of Compounds for Treating Viral Infections.' The invention covers compounds that inhibit V-ATPase activity in cells, with potential applications in treating viral infections. The patent was registered on February 25, 2026, based on application No. 2022-568620 filed in May 2021. The company stated this strengthens its intellectual property protection in Japan and adds value to its antiviral therapeutics portfolio. No commercial timeline, revenue impact, or partnership details were disclosed.
Positive long-term signal for the company's R&D pipeline in antiviral therapeutics, but limited near-term impact on stock price as no commercialisation plans or revenue contribution were indicated. Shareholders may view this as incremental progress in the company's bio-pharma diversification efforts.